174 related articles for article (PubMed ID: 19809436)
21. Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.
Mornex F; Resbeut M; Richaud P; Jung GM; Mirabel X; Marchal C; Lagrange JL; Rambert P; Chaplain G; Nguyen TD
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):651-9. PubMed ID: 7790251
[TBL] [Abstract][Full Text] [Related]
22. Treatment of invasive thymoma with single-agent ifosfamide.
Highley MS; Underhill CR; Parnis FX; Karapetis C; Rankin E; Dussek J; Bryant B; Rowland C; Hodson N; Hughes J; Harper PG
J Clin Oncol; 1999 Sep; 17(9):2737-44. PubMed ID: 10561348
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
[TBL] [Abstract][Full Text] [Related]
24. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N
Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
[TBL] [Abstract][Full Text] [Related]
25. Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial.
Conforti F; Zucali PA; Pala L; Catania C; Bagnardi V; Sala I; Della Vigna P; Perrino M; Zagami P; Corti C; Stucchi S; Barberis M; Guerini-Rocco E; Di Venosa B; De Vincenzo F; Cordua N; Santoro A; Giaccone G; De Pas TM
Lancet Oncol; 2022 Oct; 23(10):1287-1296. PubMed ID: 36096156
[TBL] [Abstract][Full Text] [Related]
26. A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.
Hirai F; Yamanaka T; Taguchi K; Daga H; Ono A; Tanaka K; Kogure Y; Shimizu J; Kimura T; Fukuoka J; Iwamoto Y; Sasaki H; Takeda K; Seto T; Ichinose Y; Nakagawa K; Nakanishi Y;
Ann Oncol; 2015 Feb; 26(2):363-8. PubMed ID: 25403584
[TBL] [Abstract][Full Text] [Related]
27. Results of S-1-based chemotherapy for platinum (and antrathycline)-refractory advanced thymic carcinoma.
Hirai F; Seto T; Inamasu E; Toyokawa G; Yoshida T; Nosaki K; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Anticancer Res; 2014 Oct; 34(10):5743-7. PubMed ID: 25275083
[TBL] [Abstract][Full Text] [Related]
28. Combination chemotherapy with a five-drug regimen for invasive thymoma.
Bjerrum OW; Kiss K; Daugaard G
Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
[TBL] [Abstract][Full Text] [Related]
29. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
Yoh K; Goto K; Ishii G; Niho S; Ohmatsu H; Kubota K; Kakinuma R; Nagai K; Suga M; Nishiwaki Y
Cancer; 2003 Sep; 98(5):926-31. PubMed ID: 12942558
[TBL] [Abstract][Full Text] [Related]
30. [A giant invasive thymoma made resectable by cisplatin + vincristine + doxorubicin + etoposide (CODE)].
Hosokawa T; Maki H; Saito T; Harada M; Isobe H
Gan To Kagaku Ryoho; 1999 Apr; 26(5):697-701. PubMed ID: 10234303
[TBL] [Abstract][Full Text] [Related]
31. Multimodality treatments in locally advanced stage thymomas.
Hassan M; Seoud DE
Hematol Oncol Stem Cell Ther; 2009; 2(2):340-4. PubMed ID: 20118057
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy for thymic carcinoma and advanced thymoma in adults.
Wei ML; Kang D; Gu L; Qiu M; Zhengyin L; Mu Y
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008588. PubMed ID: 23970462
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens.
Ma WL; Lin CC; Hsu FM; Lee JM; Chen JS; Huang YL; Chang YL; Chang CH; Yang JC
Cancer Med; 2022 Sep; 11(18):3445-3456. PubMed ID: 35348307
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.
Loehrer PJ; Perez CA; Roth LM; Greco A; Livingston RB; Einhorn LH
Ann Intern Med; 1990 Oct; 113(7):520-4. PubMed ID: 2203292
[TBL] [Abstract][Full Text] [Related]
35. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
Loehrer PJ; Wang W; Johnson DH; Aisner SC; Ettinger DS;
J Clin Oncol; 2004 Jan; 22(2):293-9. PubMed ID: 14722038
[TBL] [Abstract][Full Text] [Related]
36. [Medical treatment for thymoma: an update].
Lalle M; Bellini V; Antimi M
Clin Ter; 2008; 159(2):91-5. PubMed ID: 18463767
[TBL] [Abstract][Full Text] [Related]
37. Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: a single-institution experience.
Yellin A; Simansky DA; Ben-Avi R; Perelman M; Zeitlin N; Refaely Y; Ben-Nun A
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):83-7; discussion 87-9. PubMed ID: 23111024
[TBL] [Abstract][Full Text] [Related]
38. A pilot study of cisplatin and etoposide with and without radiotherapy for advanced malignant thymoma.
Tamiya A; Matsumura A; Tsuji T; Morimoto M; Asami K; Okishio K; Shimizu S; Yoon HE; Atagi S; Akira M; Kitaichi M; Kawaguchi T
Anticancer Res; 2014 Apr; 34(4):2023-7. PubMed ID: 24692742
[TBL] [Abstract][Full Text] [Related]
39. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]